Advanced glycation end products promote the progression of endometrial cancer via activating the RAGE/CHKA/PI3K/AKT signaling pathway

被引:2
作者
Shu, Wan [1 ]
Hua, Teng [1 ]
Xin, Xiaoyan [1 ]
Zhang, Jun [1 ]
Lin, Jing [1 ]
Shi, Rui [1 ]
Zhao, Rong [1 ]
Zhang, Wei [1 ]
Dong, Ke-jun [1 ]
Wang, Hongbo [1 ,2 ]
Zhou, Xing [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Res Ctr Canc Immunotherapy, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
endometrial cancer; AGEs; CHKA; RAGE; timosaponin A3; CHOLINE PHOSPHOLIPID-METABOLISM; KINASE-ALPHA;
D O I
10.1093/carcin/bgae059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometrial cancer (EC) is a common malignant tumor that is closely associated with metabolic disorders such as diabetes and obesity. Advanced glycation end products (AGEs) are complex polymers formed by the reaction of reducing sugars with the amino groups of biomacromolecules, mediating the occurrence and development of many chronic metabolic diseases. Recent research has demonstrated that the accumulation of AGEs can affect the tumor microenvironment, metabolism, and signaling pathways, thereby affecting the malignant progression of tumors. However, the mechanism by which AGEs affect EC is unclear. Our research aimed to investigate how AGEs promote the development of EC through metabolic pathways and to explore their potential underlying mechanisms. Our experimental results demonstrated that AGEs upregulated the choline metabolism mediated by choline kinase alpha (CHKA) through the receptor for advanced glycation end products, activating the PI3K/AKT pathway and enhancing the malignant biological behavior of EC cells. Virtual screening and molecular dynamics simulation revealed that timosaponin A3 could target CHKA to inhibit AGE-induced progression of EC and that a newly discovered CHKA inhibitor could be a novel targeted inhibitor for the treatment of EC. This study provides new therapeutic strategies and contributes to the treatment of EC. Advanced glycation end products (AGEs) promote the progression of endometrial cancer via activating the RAGE/CHKA/PI3K/AKT signaling pathway. Virtual screening and molecular dynamics simulation revealed that timosaponin A3 (timo A3) could target CHKA to inhibit AGE-induced progression of EC.
引用
收藏
页数:16
相关论文
共 45 条
  • [11] Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes
    Heidari, Firouzeh
    Rabizadeh, Soghra
    Mansournia, Mohammad Ali
    Mirmiranpoor, Hossein
    Salehi, Salome Sadat
    Akhavan, Setare
    Esteghamati, Alireza
    Naldijavani, Manouchehr
    [J]. CYTOKINE, 2019, 120 : 186 - 190
  • [12] Crystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3 SINGLE AMINO ACID NEAR THE ACTIVE SITE INFLUENCES INHIBITOR SENSITIVITY
    Hong, Bum Soo
    Allali-Hassani, Abdellah
    Tempel, Wolfram
    Finerty, Patrick J., Jr.
    MacKenzie, Farrell
    Dimov, Svetoslav
    Vedadi, Masoud
    Park, Hee-Won
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (21) : 16330 - 16340
  • [13] KEGG: new perspectives on genomes, pathways, diseases and drugs
    Kanehisa, Minoru
    Furumichi, Miho
    Tanabe, Mao
    Sato, Yoko
    Morishima, Kanae
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D353 - D361
  • [14] Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis
    Kim, Ki Mo
    Im, A-Rang
    Kim, Seung Hyung
    Hyun, Jin Won
    Chae, Sungwook
    [J]. CANCER SCIENCE, 2016, 107 (02) : 181 - 188
  • [15] Advanced glycation end products promote triple negative breast cancer cells via ERK and NF-κB pathway
    Lee, Kyung Jin
    Yoo, Ji Won
    Kim, Yun Kyu
    Choi, Jae Ho
    Ha, Tae-Yong
    Gil, Minchan
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (03) : 2195 - 2201
  • [16] Review: Diabetes, Obesity, and Cancer-Pathophysiology and Clinical Implications
    Lega, Iliana C.
    Lipscombe, Lorraine L.
    [J]. ENDOCRINE REVIEWS, 2020, 41 (01) : 33 - 52
  • [17] DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism
    Li, Zhenzhen
    Tan, Yue
    Li, Xiang
    Quan, Jing
    Bode, Ann M.
    Cao, Ya
    Luo, Xiangjian
    [J]. CELL DEATH & DISEASE, 2022, 13 (10)
  • [18] AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway
    Liu, Zhongwei
    Zhu, Haitao
    Ma, Yanpeng
    Tang, Zhiguo
    Zhao, Na
    Wang, Yuan
    Pan, Shuo
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 117
  • [19] Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine
    Malito, Enrico
    Sekulic, Nikolina
    Too, Wei Cun See
    Konrad, Manfred
    Lavie, Arnon
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2006, 364 (02) : 136 - 151
  • [20] Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities
    Martin-Carro, Beatriz
    Donate-Correa, Javier
    Fernandez-Villabrille, Sara
    Martin-Virgala, Julia
    Panizo, Sara
    Carrillo-Lopez, Natalia
    Martinez-Arias, Laura
    Navarro-Gonzalez, Juan F. F.
    Naves-Diaz, Manuel
    Fernandez-Martin, Jose L.
    Alonso-Montes, Cristina
    Cannata-Andia, Jorge B.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)